Clinical Efficacy of Supraclavicular Block for Arthroscopic Shoulder Surgery

Sponsor
Daegu Catholic University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01958801
Collaborator
(none)
104
1
2
5.9
17.5

Study Details

Study Description

Brief Summary

The aim of this study is to compare the efficacy of supraclavicular and interscalene brachial plexus blocks in the patients undergoing arthroscopic shoulder surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Supraclavicular block
  • Other: Interscalene block
N/A

Detailed Description

This study aims to compare supraclavicular brachial plexus block to interscalene brachial plexus block with regard to degree of sensory and motor blockades, side effects and complications of the blocks, and frequency of intraoperative analgesics or antihypertensives use.

Study Design

Study Type:
Interventional
Actual Enrollment :
104 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Official Title:
Comparison Between Ultrasound-guided Supraclavicular and Interscalene Brachial Plexus Blocks in the Patients Undergoing Arthroscopic Shoulder Surgery
Study Start Date :
Sep 1, 2013
Actual Primary Completion Date :
Mar 1, 2014
Actual Study Completion Date :
Mar 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Interscalene block

Interscalene block is performed under ultrasound guidance. Linear probe is placed on the ipsilateral interscalene groove visualizing the brachial plexus located between anterior and middle scalene muscles. Using in-plane technique, nerve stimulation needle is advanced into the brachial plexus sheath, into which 25 ml of 1.5% mepivacaine is injected.

Other: Interscalene block
Redirection of the needle is allowed when spread of local anesthetics does not surround the brachial plexus appropriately and involuntary movement of the forearm or hand is not necessary to confirm the correct placement of the needle.

Experimental: Supraclavicular block

Supraclavicular block is performed under ultrasound guidance. Linear probe is placed on the ipsilateral supraclavicular fossa visualizing the brachial plexus located lateral to the subclavian artery. Using in-plane technique, nerve stimulation needle is advanced into the brachial plexus sheath, into which 25 ml of 1.5% mepivacaine is injected.

Other: Supraclavicular block
Redirection of the needle is allowed when spread of local anesthetics does not surround the brachial plexus appropriately and involuntary movement of the forearm or hand is not necessary to confirm the correct placement of the needle.

Outcome Measures

Primary Outcome Measures

  1. Degree of sensory blockade [20 minutes after the end of local anesthetics injection]

    Sensory blockade of the C5 to T1 dermatomes was assessed by rating the absence of cold sensation between 100 (intact sensation) and 0 (no sensation) with an alcohol swab.

Secondary Outcome Measures

  1. Degree of motor blockade [20 minutes after the end of local anethetics injection]

    Motor blockade was evaluated by elbow and wrist extension (radial nerve), finger abduction (ulnar nerve), wrist flexion (median nerve), and elbow flexion (musculocutaneous nerve). The muscle force was rated on a scale of 0 to 6 as follows (6: normal muscle force; 5: slightly reduced muscle force; 4: greatly reduced muscle force; 3: slightly impaired mobility; 2: greatly impaired mobility; 1: near complete paralysis; 0: complete paralysis).

  2. Side effects [20 minutes after the end of local anethetics injection]

    Horner's syndrome (ptosis, miosis, anhidrosis) Subjective dyspnea Hoarseness

  3. Frequency of intraoperative analgesics or antihypertensives use [At the end of the surgery]

    Frequency of intraoperative use of opioids (fentanyl) or antihypertensives (hydralazine)

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • American Society of Anesthesiologists physical status I-II

  • Body mass index < 35 kg/m2

Exclusion Criteria:
  • Neurologic deficits on the side to be blocked

  • Infection or inflammation at the puncture site for brachial plexus block

  • Psychiatric disorders

  • Patient refusal

  • Difficulty to communicate

  • Coagulation deficiencies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Daegu Catholic University Medical Center Daegu Korea, Republic of 705-718

Sponsors and Collaborators

  • Daegu Catholic University Medical Center

Investigators

  • Principal Investigator: JongHae Kim, Master, Daegu Catholic University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
JongHae Kim, Assistant Professor, Daegu Catholic University Medical Center
ClinicalTrials.gov Identifier:
NCT01958801
Other Study ID Numbers:
  • CR-13-033
First Posted:
Oct 9, 2013
Last Update Posted:
Apr 8, 2014
Last Verified:
Apr 1, 2014
Keywords provided by JongHae Kim, Assistant Professor, Daegu Catholic University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2014